Myovant Sciences Ltd. (NYSE:MYOV) went down by -4.78% from its latest closing price compared to the recent 1-year high of $30.90. The company’s stock price has collected -8.24% of loss in the last five trading sessions. Press Release reported on 04/05/21 that Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer
Is It Worth Investing in Myovant Sciences Ltd. (NYSE :MYOV) Right Now?
Plus, the 36-month beta value for MYOV is at 2.92. Opinions of the stock are interesting as 4 analysts out of 7 who provided ratings for Myovant Sciences Ltd. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $37.50. MYOV currently public float of 32.77M and currently shorts hold a 10.59% ratio of that float. Today, the average trading volume of MYOV was 945.33K shares.
MYOV’s Market Performance
MYOV stocks went down by -8.24% for the week, with a monthly drop of -13.52% and a quarterly performance of -23.76%, while its annual performance rate touched 134.28%. The volatility ratio for the week stands at 4.11% while the volatility levels for the past 30 days are set at 5.75% for Myovant Sciences Ltd.. The simple moving average for the period of the last 20 days is -16.24% for MYOV stocks with a simple moving average of -6.23% for the last 200 days.
Analysts’ Opinion of MYOV
Many brokerage firms have already submitted their reports for MYOV stocks, with SVB Leerink repeating the rating for MYOV by listing it as a “Mkt Perform.” The predicted price for MYOV in the upcoming period, according to SVB Leerink is $28 based on the research report published on January 08th of the current year 2021.
Goldman, on the other hand, stated in their research note that they expect to see MYOV reach a price target of $30. The rating they have provided for MYOV stocks is “Neutral” according to the report published on January 06th, 2021.
Citigroup gave a rating of “Neutral” to MYOV, setting the target price at $15 in the report published on February 03rd of the previous year.
MYOV Trading at -16.68% from the 50-Day Moving Average
After a stumble in the market that brought MYOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.74% of loss for the given period.
Volatility was left at 5.75%, however, over the last 30 days, the volatility rate increased by 4.11%, as shares sank -14.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.25% lower at present.
During the last 5 trading sessions, MYOV fell by -8.24%, which changed the moving average for the period of 200-days by +13.35% in comparison to the 20-day moving average, which settled at $22.44. In addition, Myovant Sciences Ltd. saw -31.46% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MYOV starting from Arjona Ferreira Juan Camilo, who sale 7,000 shares at the price of $24.17 back on Mar 19. After this action, Arjona Ferreira Juan Camilo now owns 134,535 shares of Myovant Sciences Ltd., valued at $169,190 using the latest closing price.
Lang Matthew, the General Counsel & Corp. Secy. of Myovant Sciences Ltd., sale 30,000 shares at $25.07 during a trade that took place back on Mar 15, which means that Lang Matthew is holding 145,865 shares at $752,013 based on the most recent closing price.
Stock Fundamentals for MYOV
The total capital return value is set at -451.93, while invested capital returns managed to touch -507.03. Equity return is now at value 133.80, with -83.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.